Featured in LiveMint- GR Infra IPO
Abhay Doshi, Founder, UnlistedArena.com said, "GR Infra is an EPC company having expertise in design and construction of Road-Highway projects. They have recently ventured in railway projects too. The company has a strong order book of almost ₹19,000 crores. They have established track record of timely execution of projects which show-cases their operational efficiency."
"On the operational front, the company has witnessed fastest growth in operating income at 47% CAGR from FY15 to FY20. The issue is quite reasonably priced compared to its peers. The P/E ratio stands at 8.5x FY21 earnings, which leaves enough on the table for investors, Abhay Doshi of UnlistedArena.com concluded.
Featured in Financial Express- India Pesticides IPO
India Pesticides is well-positioned in the business which is reflected in its financial performance, said an analyst. “There is a possibility that the stock may list around Rs 320-350 which may look marginal given the combination of reasonable valuations and growth. However, it would be interesting to watch how the market assigns the value post listing,” Abhay Doshi, Founder, UnlistedArena.com, dealing in Pre-IPO & Unlisted Shares, told Financial Express Online.
Featured in LiveMint- India Pesticides IPO Listing.
Abhay Doshi, Founder at UnlistedArena.com said, "Grey market premium reflects short-term sentiment while financials of the company reflects long-term fundamentals. So, it's financials of the company that matters the most instead of the GMP of an IPO."
Featured in Business Standard- India Pesticides IPO Listing
"India Pesticides is well positioned in the business which is reflected in its financial performance. Besides, chemical sector stocks are performing well in markets which should also boost the sentiment," said Manan Doshi, co-founder of UnlistedArena.com. There is a possibility that the stock may list around Rs 320-350, which may look marginal given the combination of reasonable valuations and growth, Doshi added.
Featured in Business Standard- Shyam Metalics IPO Listing
"Shyam Metalics is expected to list on a strong note as the IPO valuations were reasonable and the company has good growth prospects. That apart, metal stocks are doing well on bourses and that will also aid the sentiment. The company has good expansion plans in the medium term, and even after listing the stock will in focus," said Manan Doshi, co-founder at UnlistedArena.com.
Featured in Business Standard- India Pesticides IPO
"Fundamentals of the company look very attractive. It has a high ROCE and ROE and a constantly growing EBITDA margins of 29.2 per cent. With strong fundamentals, the asking price of Rs 296 per share looks very reasonable. The combination of growth and reasonable valuations should prove to be the catalyst for the IPO," said Manan Doshi, co-founder of UnlistedArena.com.
Featured in LiveMint- India Pesticides IPO
Abhay Doshi, Founder, UnlistedArena.com said, "Fundamentals of the company looks very attractive. Company has high ROCE of 45.18 per cent, ROE of 35.63 per cent and constantly growing EBITDA Margins of 29.2 per cent. With the strong fundamentals, asking price of ₹296 per share looks very reasonable.
Combination of Growth & reasonable valuations should prove to be catalyst for the IPO."
Featured in LiveMint- Shyam Metalics IPO
Abhay Doshi, Founder, UnlistedArena.com said, "Higher Shyam Metalics IPO augurs sentiments in favour of higher listing. But, if we go by the financials, it is also indicating strong listing. So, both sentiment and financials are giving strong listing of the public issue."
Featured in Money9- Sona BLW IPO
“On the financial front based on annualised FY21 EPS (earnings per share), the PE (price to earnings ratio) comes around 80x while the Price/Book Value comes around 12.93x which makes the issue costly which may result into a dull response. However, the company may get benefitted from the electric vehicle theme so, it would be prudent to watch the performance of upcoming quarters,” explained grey market tracker Abhay Doshi, Founder of Unlisted Arena.
Featured in Money9- KIMS IPO
“The company has delivered a capable performance in the last couple of years. There has been a healthy growth in both EBITDA (earnings before interest tax depreciation and amortisation) and margins. The company reported a 48% CAGR (compounded annual growth rate) in EBITDA and the EBITDA margins grew from 18.83% to 28.43% from FY19-FY21. The bed occupancy ratio is healthy around 80%. They have retained over 80% of doctors since its inception,” said explained grey market tracker Abhay Doshi, Founder of Unlisted Arena.
The issue looks fairly priced given its strong performance and prospects. The IPO should attract interest from long-term investors, added Doshi.